Bixiye
QP41-23 Makena® (hydroxyprogesterone caproate): Drug Approval Withdrawn
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1701 - 1710 ee natiijooyinka 3167
Bixiye
P31-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective July 3, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P32-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Musculoskeletal Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P33-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P25-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P26-23 2023 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P27-23 2023 Renewal Changes Summary for Suppliers of Durable Medical Equipment
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P28-23 2023 Renewal Changes Summary for Aware Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P29-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P30-23 Gender Affirming Care
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023